| scholarly article | Q13442814 |
| P2093 | author name string | Kishore Bhat | |
| Bangalore Nandha | |||
| Laxmivenkatesh Gurachar Nargund | |||
| Shachindra Laxmivenkatesh Nargund | |||
| P2860 | cites work | Design, synthesis and biological evaluation of some novel benzimidazole derivatives for their potential anticonvulsant activity | Q42956958 |
| Synthesis, vasorelaxant activity and antihypertensive effect of benzo[d]imidazole derivatives | Q43069690 | ||
| In-vivo analgesic and anti-inflammatory activities of newly synthesized benzimidazole derivatives | Q43172998 | ||
| SAR study of clubbed [1,2,4]-triazolyl with fluorobenzimidazoles as antimicrobial and antituberculosis agents | Q43974164 | ||
| Synthesis and preliminary evaluation of benzimidazole derivatives as antimicrobial agents. | Q43991349 | ||
| Synthesis and evaluation of in vitro anti-microbial and anti-tubercular activity of 2-styryl benzimidazoles. | Q45961608 | ||
| Synthesis and evaluation of a novel series of pseudo-cinnamic derivatives as antituberculosis agents | Q46197312 | ||
| Clubbed [1,2,3] triazoles by fluorine benzimidazole: a novel approach to H37Rv inhibitors as a potential treatment for tuberculosis. | Q46310260 | ||
| Comparative studies on conventional and microwave synthesis of some benzimidazole, benzothiazole and indole derivatives and testing on inhibition of hyaluronidase. | Q46607098 | ||
| Synthesis and antioxidant properties of novel N-methyl-1,3,4-thiadiazol-2-amine and 4-methyl-2H-1,2,4-triazole-3(4H)-thione derivatives of benzimidazole class | Q46705117 | ||
| Synthesis and antiprotozoal activity of some 2-(trifluoromethyl)-1H-benzimidazole bioisosteres | Q46783558 | ||
| Inhibition of bacterial cell division protein FtsZ by cinnamaldehyde. | Q53537364 | ||
| Identification of cell cycle regulators in Mycobacterium tuberculosis by inhibition of septum formation and global transcriptional analysis | Q61787756 | ||
| Quinoline alkaloids from Lunasia amara inhibit Mycobacterium tuberculosis H37Rv in vitro | Q63363590 | ||
| Synthesis of benzimidazole derivatives as antiallergic agents with 5-lipoxygenase inhibiting action | Q73289729 | ||
| Design, synthesis and antitumor cytotoxicity of novel bis-benzimidazoles | Q73493378 | ||
| Piperonylic acid, a selective, mechanism-based inactivator of the trans-cinnamate 4-hydroxylase: A new tool to control the flux of metabolites in the phenylpropanoid pathway | Q95437896 | ||
| Activity against Mycobacterium tuberculosis of alkaloid constituents of Angostura bark, Galipea officinalis | Q28374968 | ||
| Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium | Q28378889 | ||
| Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay | Q28379335 | ||
| Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability | Q29617252 | ||
| Design, synthesis and evaluation of novel 2,5,6-trisubstituted benzimidazoles targeting FtsZ as antitubercular agents. | Q33711825 | ||
| Novel trisubstituted benzimidazoles, targeting Mtb FtsZ, as a new class of antitubercular agents | Q33761632 | ||
| In vitro-in vivo activity relationship of substituted benzimidazole cell division inhibitors with activity against Mycobacterium tuberculosis | Q33797084 | ||
| Antimycobacterial natural products | Q35618520 | ||
| New perspectives on natural products in TB drug research | Q36294148 | ||
| Natural product growth inhibitors of Mycobacterium tuberculosis. | Q36772385 | ||
| SAR studies on trisubstituted benzimidazoles as inhibitors of Mtb FtsZ for the development of novel antitubercular agents | Q37600601 | ||
| Simple Synthesis and Biological Evaluation of Some Benzimidazoles Using Sodium Hexafluroaluminate, Na 3 AlF 6 , as an Efficient Catalyst | Q37700648 | ||
| Zanthoxylum capense constituents with antimycobacterial activity against Mycobacterium tuberculosis in vitro and ex vivo within human macrophages. | Q39207272 | ||
| Discovery of benzimidazole derivatives as novel multi-target EGFR, VEGFR-2 and PDGFR kinase inhibitors | Q39513979 | ||
| Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside reverse transcriptase inhibitors | Q39967417 | ||
| Synthesis, antiprotozoal and anticancer activity of substituted 2-trifluoromethyl- and 2-pentafluoroethylbenzimidazoles | Q40661081 | ||
| Design and Synthesis of New Benzimidazole and Pyrimidine Derivatives as α-glucosidase Inhibitor | Q41836177 | ||
| Benzimidazole-based compounds kill Mycobacterium tuberculosis | Q42227583 | ||
| Design, synthesis and antitubercular evaluation of novel series of N-[4-(piperazin-1-yl)phenyl]cinnamamide derivatives | Q42706843 | ||
| Design, synthesis, and biological evaluation of new cinnamic derivatives as antituberculosis agents | Q42751415 | ||
| P433 | issue | 3 | |
| P921 | main subject | natural product | Q901227 |
| P304 | page(s) | 929-942 | |
| P577 | publication date | 2017-01-01 | |
| P1433 | published in | Iranian journal of pharmaceutical research | Q20183787 |
| P1476 | title | Design and Synthesis of Some Novel Fluorobenzimidazoles Substituted with Structural Motifs Present in Physiologically Active Natural Products for Antitubercular Activity. | |
| P478 | volume | 16 |
| Q57928149 | Investigation of the anti-TB potential of selected propolis constituents using a molecular docking approach | cites work | P2860 |
Search more.